Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.

about

The Epigenetic Machinery in Vascular Dysfunction and Hypertension.

P2860

Q39328207-044262CC-F8D0-4B05-9CFC-E573898FA952

P2860

Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.

Item

http://www.wikidata.org/entity/Q39157832

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Protective effects of nebivolo ...... n-related target organ damage.

@en

Protective effects of nebivolo ...... n-related target organ damage.

@nl

type

Item

label

Protective effects of nebivolo ...... n-related target organ damage.

@en

Protective effects of nebivolo ...... n-related target organ damage.

@nl

prefLabel

Protective effects of nebivolo ...... n-related target organ damage.

@en

Protective effects of nebivolo ...... n-related target organ damage.

@nl

P1476

Protective effects of nebivolo ...... n-related target organ damage.

@en

P2093

A Coats

http://www.w3.org/2001/XMLSchema#string

S Jain

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

P2860

Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation

Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension

Nebivolol in the management of essential hypertension: a review.

Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care).

End organ damage in hypertension.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

Nebivolol: impact on cardiac and endothelial function and clinical utility.

Recent insights in the development of organ damage caused by hypertension.

Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension.

Mechanisms of target organ damage caused by hypertension: therapeutic potential.

P2888

jhh.2017.8

P304

376-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1038/JHH.2017.8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28252041

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

5418557

http://www.w3.org/2001/XMLSchema#string

Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.

about

P2860

P2860

Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932